在肺腺癌中,ACAT2可能是一个新的预测生物标志物和治疗点
Zhongchao Wang1,2, Zhugen Cao3, Zhaoxia Dai1
1The Second Hospital, Dalian Medical University, Dalian, China.
Cancer reports (Hoboken, N.J.)
|January 12, 2024
概括
乙辅酶A胆固醇乙转移酶2 (ACAT2) 在肺腺癌 (LUAD) 中被上调,与更差的生存率相关. 这表明ACAT2可作为预测性生物标志物和治疗目标,用于LUAD患者.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 乙辅酶A胆固醇乙转移酶 (ACAT) 是一个内 плазма网膜局部化的酶.
- 已确定ACAT2在结肠癌中的作用,但其对肺腺癌 (LUAD) 的影响尚不清楚.
研究的目的:
- 研究LUAD中ACAT2的表达和预后意义.
- 在LUAD中探索ACAT2表达与瘤特征和生物功能之间的相关性.
主要方法:
- 使用TIMER2.0和GEPIA数据库进行ACAT2表达式分析.
- 使用卡普兰-梅尔分析和考克斯回归来评估临床预后.
- 分析了与CancerSEA的功能相关性以及与STRING的分子相互作用.
主要成果:
- 升高的ACAT2表达与LUAD中较差的无疾病生存率 (DFS) 和整体生存率 (OS) 有关.
- ACAT2的表达与瘤阶段,结节阶段和远程转移相关.
- ACAT2 影响细胞循环,DNA 修复,DNA 损伤反应和增殖,并确定了关键相关基因.
结论:
- 在LUAD中,ACAT2被上调,并与患者不良结果相关.
- ACAT2具有作为LUAD新型预测生物标志物的潜力.
- 在肺腺癌中,ACAT2可能是一个有前途的治疗标.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K